Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against <i>Clostridioides difficile</i> Infection
Background/Objectives: <i>Clostridioides difficile</i> is a Gram-positive, spore-forming enteric pathogen that causes intestinal disorders, including inflammation and diarrhea, primarily through toxin production. Standard treatment options for <i>C. difficile</i> infection (C...
Saved in:
Main Authors: | Shaohui Wang, Joshua Heuler, Jessica Bullock, Junling Qin, Soumyadeep Chakraborty, Agbendeh Lubem Nathaniel, Shifeng Wang, Xingmin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/1/21 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
by: Roberto Rosato, et al.
Published: (2024-12-01) -
Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
by: Pedro Puerta-Alcalde, et al.
Published: (2025-04-01) -
Heterogeneity of Clostridioides difficile asymptomatic colonization prevalence: a systematic review and meta-analysis
by: Daniel De-la-Rosa-Martínez, et al.
Published: (2025-01-01) -
Metronidazole and Vancomycin Have a Synergic Effect, with Plant Extracts as Helpful Tools to Combat <i>Clostridioides difficile</i> Infections
by: Nancy C. Ruiz-Pérez, et al.
Published: (2025-01-01) -
A Review of Therapies for <i>Clostridioides difficile</i> Infection
by: Faiza Morado, et al.
Published: (2024-12-01)